METHODS OF TREATING NECROTIZING ENTEROCOLITIS BY ADMINISTERING NUCLEAR OLIGOMERIZATION DOMAIN-2 AGONISTS,TLR9 AGONISTS AND TLR4 ANTAGONISTS
- 专利权人:
- University of Pittsburgh - of the Commonwealth System of Highter Education
- 发明人:
- DAVID J. HACKAM
- 申请号：
- US14010232
- 公开号：
- US20160303229A9
- 申请日:
- 2013.08.26
- 申请国别(地区):
- US
- 年份:
- 2016
- 代理人:
- 摘要：
- The present invention relates to the use of a TLR9 agonist and/or a TLR4 antagonist and/or a NOD2 agonist for treatment or prevention of disorders involving TLR4 activation, such as systemic sepsis and necrotizing enterocolitis.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of toll-like receptor-4-associated disorders
- USE OF TOLL-LIKE RECEPTOR-9 AGONISTS, TOLL-LIKE RECEPTOR-4 ANTAGONISTS, AND/OR NUCLEAR OLIGOMERIZATION DOMAIN-2 AGONISTS FOR THE TREATMENT OF PREVENTION OF TOLL-LIKE RECEPTOR-4-ASSOCIATED DISORDERS
- Use of Toll-like receptor-9 agonists, Toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of Toll-like receptor-4-associated disorders
- הרכבים ושיטות להסדיר צמיחה של שיער
- TREATMENT USING TRUNCATED TRK B AND TRK C ANTAGONISTS
